Risk appetite in currency markets was boosted by progress towards a COVID-19 vaccine rollout even as PMI data showed a sharp contraction in euro zone business activity as a result of lockdown restrictions.
AstraZeneca on Monday said that its vaccine could be about 90% effective and it will prepare to submit...
